Welcome to our dedicated page for Ingersoll-Rand news (Ticker: IR), a resource for investors and traders seeking the latest updates and insights on Ingersoll-Rand stock.
Ingersoll Rand Inc. (NYSE: IR) delivers mission-critical industrial technologies and precision solutions across global markets. This dedicated news hub provides investors and industry professionals with authoritative updates on the company’s strategic initiatives, financial performance, and technological advancements.
Access real-time announcements including quarterly earnings reports, product innovation launches, and strategic partnership developments. Our curated feed consolidates press releases and verified news articles about IR’s industrial compression systems, fluid management solutions, and precision engineering breakthroughs.
Key coverage areas include operational expansions in energy-efficient technologies, updates on medical-grade equipment certifications, and analysis of market positioning within industrial manufacturing sectors. Bookmark this page for streamlined tracking of IR’s progress in advancing sustainable industrial practices and mission-critical flow control solutions.
Ingersoll Rand (NYSE: IR) has released its 2023 Sustainability Report, highlighting significant achievements and new goals. The company focuses on two main areas: 'Grow Sustainably' and 'Operate Sustainably.'
Key accomplishments include launching 80 new sustainable products, with 66% of its portfolio featuring sustainable attributes, expecting these to account for over 25% of revenue by 2030. The company supports high-growth markets like clean energy and life sciences.
Operational achievements include surpassing industry safety standards by 73%, granting equity to over 23,000 employees since 2017, powering 45 sites with renewable energy, and achieving a water reduction goal seven years early. Ingersoll Rand has been recognized on the CDP 'A List' and Dow Jones Sustainability Indices.
New goals include reducing water usage by 30% in water-stressed sites by 2030 and helping customers reduce or avoid 1 billion metric tons of CO2e by 2040.
Ingersoll Rand has appointed Scott Watson, former Chief Operating Officer of ILC Dover, as the Senior Vice President and General Manager of its Life Science Technologies platform. The appointment is effective immediately, succeeding Corey Walker. Scott will oversee global strategy, operations, and new product development, and from January 2025, he will manage the legacy Ingersoll Rand medical business. Known for his operational expertise and strategic leadership, Scott has a strong track record in driving growth and operational excellence at ILC Dover.
Ingersoll Rand's CEO, Vicente Reynal, expressed confidence in Scott's ability to continue the company's success, highlighting his extensive experience in revenue generation and operational management. Scott holds advanced degrees from Northwestern University and Ohio University, emphasizing his strong academic background in business and engineering management.
Ingersoll Rand (NYSE: IR), a global provider of industrial solutions, announced participation in the Wells Fargo 2024 Industrials Conference. CFO Vik Kini and VP Matthew Fort will join a fireside chat on June 11, 2024, at 9:00 a.m. ET. The session will be webcast live and available for replay on the Ingersoll Rand Investor Relations website.
Ingersoll Rand has finalized the acquisition of ILC Dover for $2.325 billion, expanding its market reach to $65 billion. Additionally, the company acquired Complete Air and Power Solutions, Del PD Pumps & Gear Pvt , and Fruitland Manufacturing for $150 million. These acquisitions aim to enhance Ingersoll Rand's portfolio in sustainable markets such as life sciences, food and beverage, medical, and wastewater treatment. The company demonstrates its commitment to achieving mid-teens return on invested capital within three years post-acquisition.
Ingersoll Rand (NYSE: IR) announced that CFO Vik Kini and VP Matthew Fort will participate in the Wolfe 17th Annual Global Transportation and Industrials Conference. The event will take place on May 22, 2024, at 8:00 a.m. Eastern Time. A fireside chat will be webcast live and will be available for replay on the company's Investor Relations website. This participation highlights the company's ongoing engagement with investors and stakeholders, providing insights into its financial strategies and business outlook.
Ingersoll Rand Inc. successfully completed a $3,300 million Senior Unsecured Bond Offering and established a new $2,600 million Senior Unsecured Revolving Credit Facility. The funds raised will be used for various purposes, including the repayment of term loans, funding an acquisition, and general corporate uses. The company also received an upgrade in its credit ratings by all three major agencies, reflecting its strong financial performance and improved capital structure.
Ingersoll Rand has led a $19M financing round for Inkbit, a pioneer in advanced additive manufacturing solutions. The funding will advance Inkbit's Vision-Controlled Jetting™ (VCJ) technology, enabling rapid manufacturing of innovative products like complex industrial fluidics and bio-inspired robots. Inkbit's technology reimagines the traditional assembly line, combining scalability, reliability, and intelligence to build multi-functional products in one pass.
Ingersoll Rand reported record first quarter revenues, Adjusted EBITDA, and Adjusted EPS. The company raised its total company Adjusted EBITDA and Adjusted EPS guidance for 2024, showcasing a strong performance driven by Ingersoll Rand Execution Excellence (IRX). Despite a decline in orders, the two-year stack shows an improvement, with reported revenues and net income also on the rise. The company maintains a healthy liquidity of $3.5 billion and has raised its 2024 guidance for Adjusted EBITDA and Adjusted EPS. Ingersoll Rand is focused on delivering long-term value to shareholders through strategic acquisitions and comprehensive capital allocation strategies.
Ultima Genomics, a developer of an innovative ultra-high throughput sequencing architecture, announced the addition of Mark Stevenson, a seasoned executive with over 30 years of experience in the life sciences sector, to its Board of Directors. Stevenson, the former Executive Vice President and COO of Thermo Fisher Scientific, brings valuable expertise in next-generation sequencing technologies and innovation. His appointment is expected to bolster Ultima Genomics' position in the genomics and healthcare fields.
FAQ
What is the current stock price of Ingersoll-Rand (IR)?
What is the market cap of Ingersoll-Rand (IR)?
